Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ILV-095
BIOLOGICAL
2 trials
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions
Healthy Subjects
Phase 1
Study Evaluating Single Doses of ILV-095 in Healthy Japanese Male Subjects
Completed
NCT00822484
Wyeth is now a wholly owned subsidiary of Pfizer
Healthy Subjects
Start: 2009-02-28
End: 2009-09-30
Updated: 2011-05-06
Study Evaluating Single Doses of ILV-095 in Healthy Subjects
Completed
NCT00822835
Wyeth is now a wholly owned subsidiary of Pfizer
Healthy Subjects
Start: 2009-01-31
End: 2009-08-31
Target: 48
Updated: 2009-09-18